Concepedia

Author

Ryuta Shigefuku

St. Marianna University School of MedicineORCID

Also Known As

R Shigefuku, R. Shigefuku, RYOTA SHIGEFUKU, Ryuta Shigefuku

67

Publications

514

Citations

12

H-Index

30

Concepts

All Affiliations

St. Marianna University School of MedicineMie UniversityAnzai (Japan)Kyorin UniversityKawasaki Municipal Hospital
RS

About

Ryuta Shigefuku is an author at St. Marianna University School of Medicine specializing in medicine, hepatology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

78

2

Hepatology

4

4

65

3

Gastroenterology

3

3

52

4

Health Sciences

2

2

39

5

Microbiology

1

1

13

Ryuta Shigefuku

×

19

Publications

373

Citations

12

H-Index

YearCitations

Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma

Yasuyuki Tamai, Motoh Iwasa, Akiko Eguchi,

PLoS ONE

2020

69

Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans

Yasuyuki Tamai, Akiko Eguchi, Ryuta Shigefuku,

eLife

2022

39

Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C Virus

Ryuta Shigefuku, Hideaki Takahashi, Hiroyasu Nakano,

International Journal of Molecular Sciences

2016

31

Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?

Ryuta Shigefuku, Hideaki Takahashi, Minoru Kobayashi,

Journal of Gastroenterology

2012

29

Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus‐related liver cirrhosis

Ryuta Shigefuku, Motoh Iwasa, Kazuhiro Katayama,

Hepatology Research

2019

24

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients

Ryosuke Sugimoto, Motoh Iwasa, Akiko Eguchi,

Frontiers in Medicine

2023

20

A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis

Akiko Eguchi, Motoh Iwasa, Minori Yamada,

Hepatology Communications

2022

18

Cirrhosis improvement to alcoholic liver fibrosis after passive abstinence

Hideaki Takahashi, Ryuta Shigefuku, Shiro Maeyama,

BMJ Case Reports

2014

16

Impact of resistance‐associated variant dominancy on treatment in patients with HCV genotype 1b receiving daclatasvir/asunaprevir

Hiroki Ikeda, Tsunamasa Watanabe, Chiaki Okuse,

Journal of Medical Virology

2016

15

Accuracy of carbohydrate‐deficient transferrin as a biomarker of chronic alcohol abuse during treatment for alcoholism

Tatsuya Suzuki, Akiko Eguchi, Ryuta Shigefuku,

Hepatology Research

2021

14

Page 1